The Veterinary Record
HOME CURRENT ISSUE TABLE OF CONTENTS ARCHIVE SEARCH SUBSCRIPTIONS JOBS FEEDBACK HELP
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Hamers, C.
Right arrow Articles by Goutebroze, S.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hamers, C.
Right arrow Articles by Goutebroze, S.
The Veterinary Record 165:369-373 (2009)
© 2009 British Veterinary Association

Papers

Use of inactivated bluetongue virus serotype 8 vaccine against virulent challenge in sheep and cattle

C. Hamers, DVM, PhD1, S. Galleau, DVM1, R. Chery1, M. Blanchet1, L. Besancon, MSc2, C. Cariou, PhD2, B. Werle-Lapostolle, PhD2, P. Hudelet, DVM2 and S. Goutebroze, DVM1

1 Merial SAS, Allée des Cyprès, 01150 Saint Vulbas, France
2 Merial SAS, 254 Rue M. Merieux, 69007 Lyon, France

Correspondence: E-mail for correspondence: claude.hamers{at}merial.com

The immunisation properties of an inactivated bluetongue virus serotype 8 (BTV-8) vaccine were evaluated in sheep and cattle. Five sheep were vaccinated with one dose of vaccine and five cattle were vaccinated with two doses 28 days apart. Six sheep and five cattle served as unvaccinated controls. All animals were subjected to a virulent BTV-8 challenge, and safety and antibody responses were monitored. All control animals developed disease and viraemia, while vaccinated animals were clinically protected and viraemia was completely prevented.






HOME CURRENT ISSUE TABLE OF CONTENTS ARCHIVE SEARCH SUBSCRIPTIONS JOBS FEEDBACK HELP
Copyright © 2009 British Veterinary Association